HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons

The review analyzes the potential advantages and problems associated with using HIF prolyl hydroxylase inhibitors as a treatment for COVID-19. HIF prolyl hydroxylase inhibitors are known to boost endogenous erythropoietin (Epo) and activate erythropoiesis by stabilizing and activating the hypoxia in...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrey A. Poloznikov (Author), Stepan A. Nersisyan (Author), Dmitry M. Hushpulian (Author), Eliot H. Kazakov (Author), Alexander G. Tonevitsky (Author), Sergey V. Kazakov (Author), Valery I. Vechorko (Author), Sergey V. Nikulin (Author), Julia A. Makarova (Author), Irina G. Gazaryan (Author)
Format: Book
Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items